Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Early tumorigenesis is associated with the engagement of the DNA-damage checkpoint response (DDR). Cell proliferation and transformation induced by oncogene activation are restrained by cellular senescence. It is unclear whether DDR activation and oncogene-induced senescence (OIS) are causally linked. Here we show that senescence, triggered by the expression of an activated oncogene (H-RasV12) in normal human cells, is a consequence of the activation of a robust DDR. Experimental inactivation of DDR abrogates OIS and promotes cell transformation. DDR and OIS are established after a hyper-replicative phase occurring immediately after oncogene expression. Senescent cells arrest with partly replicated DNA and with DNA replication origins having fired multiple times. In vivo DNA labelling and molecular DNA combing reveal that oncogene activation leads to augmented numbers of active replicons and to alterations in DNA replication fork progression. We also show that oncogene expression does not trigger a DDR in the absence of DNA replication. Last, we show that oncogene activation is associated with DDR activation in a mouse model in vivo. We propose that OIS results from the enforcement of a DDR triggered by oncogene-induced DNA hyper-replication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibition of DDR signalling kinases (ATM, ATR, CHK1 and CHK2) allows senescent cells to re-enter the cell cycle7,24,25”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [7]
In the citing paper
“Oncogene activation is a powerful inducer of cellular senescence. Oncogene expression triggers an initial hyperproliferative phase that is intrinsically associated with altered DNA replication, which eventually engages DDR pathways and causes senescence7,8,39”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [7]
In the citing paper
“In normal cells, however, oncogenic RAS causes genotoxic stress and senescence [ 57 , 58 ], inducing a SASP and thereby conferring complex cell-nonautonomous oncogenic activities.”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [57]
In the citing paper
“Indeed, most oncogenes that have been studied in the literature cause replication stress by increasing origin firing and triggering DNA damage [12, 29]”
From The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia (2017) · cites this paper as [12]
In the citing paper
“It has been shown that one mechanism for the link between the initial mitotic reaction and senescence induction is the S-phase-associated DDR: The oncogenic stress drives increased DNA replication origins, leading to accumulation of incomplete replication intermediates, resulting in DNA damage and activation of the DDR kinases (ATM, ATR, CHK2, and CHK1) (Bartkova et al. 2006; Di Micco et al. 2006;”
From Cellular senescence and its effector programs (2014) · cites this paper as Di Micco et al. 2006
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Oncogenic activity of Cdc6 through repression of the INK4/ARF locus
Gonzalez, S., Klatt, P., Delgado, S., Conde, E., Lopez-Rios, F., Sanchez-Cespedes, M., Mendez, J., Antequera, F., & Serrano, M. (2006) · Nature · doi:10.1038/nature04585 · Cited by 186
RetractedA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Cited by
Items 401–500 of 1,011
Katsube, T., Mori, M., Tsuji, H., Shiomi, T., Wang, B., Liu, Q., Nenoi, M., & Onoda, M. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu021 · Cited by 99
“Because the reappearance of gH2AX 24h after the treatment was restricted in cells at the S-phase when exposed to H2O2, some kind of irreparable DNA damage may be induced in an S-phase-specific manner and such damage may lead to the continuing activation of DDR, which must have a causal role in both the initiation and…”
BackgroundHafner, C. M., Toll, A., Fernández-Casado, A., Earl, J., Marqués, M., Acquadro, F., Méndez‐Pertuz, M., Urioste, M., Malats, N., Burns, J. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008365107 · Cited by 100
“We looked for evidence of DDR by comparing γ-H2AX foci and 53BP1 expression in SK and normal skin and found no significant differences.”
BackgroundInfluentialPiunti, A., Rossi, A., Cerutti, A., Albert, M., Jammula, S., Scelfo, A., Cedrone, L., Fragola, G., Olsson, L., Koseki, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms4649 · Cited by 93
Tu, Z., Aird, K. M., Bitler, B. G., Nicodemus, J. P., Beeharry, N., Xia, B., Yen, T. J., & Zhang, R. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.10.010 · Cited by 88
“For example, oncogenic RAS mutants induce DNA damage by triggering aberrant DNA replication (Di Micco et al., 2006).”
InfluentialCipriano, R., Kan, C. E., Graham, J., Danielpour, D., Stampfer, M., & Jackson, M. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015022108 · Cited by 92
“Previous reports using fibroblasts demonstrated a requirement for DDR proteins, including ATM and CHK2, in RAS-G12V– mediated senescence (4, 9, 17).”
BackgroundThe Senescence–Stemness Alliance – A Cancer-Hijacked Regeneration Principle
Milanovic, M., Yu, Y., & Schmitt, C. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.09.001 · Cited by 92
Cellular Senescence in the Development and Treatment of Cancer
Saretzki, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210789941874 · Cited by 87
“Consistent with the observation that oncogene activation leads to DDR activation in vitro, the involvement of ATM, CHK2, 53BP1 and -H2AX-foci has been demonstrated in different tumours, such as bladder, lung, breast and colon [42, 96], although the extent of DDR activation can vary in different organsms and tissues.”
BackgroundInfluentialThe Cytolethal Distending Toxin Effects on Mammalian Cells: A DNA Damage Perspective
Bezine, E., Vignard, J., & Mirey, G. (2014) · Cells · doi:10.3390/cells3020592 · Cited by 103
“DDR downregulation prevents senescence initiation and maintenance, allowing cell proliferation and predisposing cells to oncogenic transformation [107,108].”
BackgroundNon-Cell-Autonomous Regulation of Cellular Senescence in Cancer
Mitri, D. D., & Alimonti, A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.005 · Cited by 100
Yin, S., Gambe, R. G., Sun, J., Martinez, A. Z., Cartun, Z. J., Regis, F. F., Wan, Y., Fan, J., Brooks, A. N., Herman, S. E. M., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2018.12.013 · Cited by 97
Identification of Small Molecule Inhibitors of Phosphatidylinositol 3-Kinase and Autophagy
Farkas, T., Daugaard, M., & Jäättelä, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.269134 · Cited by 91
MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways
Patel, A., Burton, D. G. A., Halvorsen, K., Balkan, W., Reiner, T., Perez‐Stable, C., Cohen, A., Munoz, A., Giribaldi, M. G., Singh, S., et al. (2014) · Oncogene · doi:10.1038/onc.2014.195 · Cited by 96
Chuang, C.-H., Wallace, M. D., Abratte, C. M., Southard, T. L., & Schimenti, J. C. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001110 · Cited by 91
“Our data contribute to a growing body of data that replication stress, which can occur via perturbations of the DNA replication machinery, plays a significant role in driving cancer [38–41].”
BackgroundGurvich, N., Perna, F., Farina, A., Voza, F., Menendez, S., Hurwitz, J., & Nimer, S. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017092108 · Cited by 89
The role of hydrogen sulfide in aging and age-related pathologies
Perridon, B. W., Leuvenink, H. G. D., Hillebrands, J., van Goor, H., & Bos, E. M. (2016) · Aging · doi:10.18632/aging.101026 · Cited by 96
“Telomere attrition [232], DNA lesions [233], oxidative stress [234] and activated oncogenes [235, 236] are examples of stressors shown to induce senescence by the activation of the DNA damage response, which arrests cell-cycle through stabilization of p53 and transcriptional activation of p21 [226].”
BackgroundWnt Antagonist SFRP1 Functions as a Secreted Mediator of Senescence
Elzi, D. J., Song, M., Hakala, K., Weintraub, S. T., & Shiio, Y. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06023-11 · Cited by 89
“Although oncogene-induced senescence was proposed as a consequence of DNA damage (3, 12), phosphorylated histone H2AX staining was not observed upon senescence induced by SFRP1, -catenin knockdown, or pyrvinium pamoate treatment (data not shown).”
BackgroundType I interferons and related pathways in cell senescence
Frisch, S. M., & MacFawn, I. P. (2020) · Aging Cell · doi:10.1111/acel.13234 · Cited by 85
“This response is thought to represent a specialized form of DNA damage signaling arising from replicative stress in response to mitogenic overstimulation (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundCellular Senescence: Mechanisms and Therapeutic Potential
Liao, Z., Yeo, H. L., Wong, S. W., & Zhao, Y. X. (2021) · Biomedicines · doi:10.3390/biomedicines9121769 · Cited by 94
“This intrinsic insult on the DNA molecules is detected by the DDR machinery and this activates replicative senescence [5].”
BackgroundInfluentialDikovskaya, D., Cole, J. J., Mason, S. M., Nixon, C., Karim, S. A., McGarry, L., Clark, W., Hewitt, R. N., Sammons, M. A., Zhu, J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.055 · Cited by 89
“…DNA damage response is a major driver of OIS (Di Micco et al., 2006), it is conceivable that damage associated with Rasinducedmitotic stress could also contribute to the establishment of senescence, in the same way that Ras-induced DNA replication stress triggers senescence (Di Micco et al., 2006).”
BackgroundTORC2 Signaling Pathway Guarantees Genome Stability in the Face of DNA Strand Breaks
Shimada, K., Filipuzzi, I., Ståhl, M., Helliwell, S. B., Studer, C., Hoepfner, D., Seeber, A., Loewith, R., Movva, N. R., & Gasser, S. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.019 · Cited by 93
“Intriguingly, oncogene activation itself triggers replication fork-associated stress and activates a low-level Molecu checkpoint response (Bartkova et al., 2006; Di Micco et al., 2006).”
Senescence and immortality in hepatocellular carcinoma
Öztürk, M., Arslan-Ergül, A., Baǧışlar, S., Şentürk, Ş., & Yuzugullu, H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.10.048 · Cited by 103
Molecular damage in cancer: an argument for mTOR-driven aging
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100422 · Cited by 90
“In oncogene-induced senescence (OIS), DDR causes cell cycle arrest, leading to senescence [238-245].”
BackgroundThe DNA damage checkpoint response to replication stress: A Game of Forks
Jossen, R., & Bermejo, R. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00026 · Cited by 107
Oncogenes create a unique landscape of fragile sites
Miron, K., Golan‐Lev, T., Dvir-Szternfeld, R., Ben‐David, E., & Kerem, B. (2015) · Nature Communications · doi:10.1038/ncomms8094 · Cited by 94
Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications
Mehraj, U., Mushtaq, U., Mir, M. A., Saleem, A., Macha, M. A., Lone, M. N., Hamid, A., Zargar, M. A., Ahmad, S. M., & Wani, N. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.008 · Cited by 93
Pathogenesis of cancers derived from thyroid follicular cells
Fagin, J. A., Krishnamoorthy, G. P., & Landa, I. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00598-y · Cited by 94
NADPH oxidases 1 and 4 mediate cellular senescence induced by resveratrol in human endothelial cells
Schilder, Y. D. C., Heiß, E. H., Schachner, D., Ziegler, J., Reznicek, G., Sorescu, D., & Dirsch, V. M. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.03.013 · Cited by 96
“showed that S-phase stress is a trigger for oncogene-induced senescence in neoplasia [22].”
BackgroundSantoriello, C., Deflorian, G., Pezzimenti, F., Kawakami, K., Lanfrancone, L., d’Adda di Fagagna, F., & Mione, M. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001016 · Cited by 87
“…in particular a constitutively active form carrying a mutation, in which a GGC codon is substituted with a GTC codon (G12V, or in short V12), because its roles in transformation and cellular senescence are well documented (Kraus et al., 1984; Barbacid, 1990; Downward, 1996; Di Micco et al., 2006).”
Two sides of the Myc-induced DNA damage response: from tumor suppression to tumor maintenance
Campaner, S., & Amati, B. B. (2012) · Cell Division · doi:10.1186/1747-1028-7-6 · Cited by 94
“Several evidences lead to surmise that a strong component of the DDR activation relies on DNA damage triggered by replication stress [48,49].”
BackgroundDormant cancer cells: programmed quiescence, senescence, or both?
Truskowski, K., Amend, S. R., & Pienta, K. J. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10073-z · Cited by 92
“Importantly, evidence has also accumulated pointing to roles for senescence during tumorigenesis [3, 22, 25, 30, 47, 48].”
BackgroundMYC and the Control of DNA Replication
Dominguez-Sola, D., & Gautier, J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014423 · Cited by 85
Is DNA damage indispensable for stress-induced senescence?
Bielak-Żmijewska, A., Mosieniak, G., & Sikora, E. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.004 · Cited by 92
SIRT1 modulates cell cycle progression by regulating CHK2 acetylation−phosphorylation
Zhang, W., Feng, Y., Guo, Q., Guo, W., Xu, H., Li, X., Yi, F., Guan, Y., Geng, N., Wang, P., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0369-7 · Cited by 84
Liu, B., Peng, Z., Zhang, H., Zhang, N., Liu, Z., Xia, Z., Huang, S., Luo, P., & Cheng, Q. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02284-z · Cited by 105
Non-cell autonomous effects of the senescence-associated secretory phenotype in cancer therapy.
Saleh, T., Tyutynuk-Massey, L., Cudjoe, E. K., Idowu, M. O., Landry, J. W., & Gewirtz, D. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00164 · Cited by 85
“The SASP can be a direct consequence of the activation of the DNA damage response (DDR) which is uniformly induced in tumor cells treated with chemotherapy or radiation (12, 13) and can also result from oncogene overexpression and hyper DNA replication (14).”
BackgroundEvidence of sex differences in cellular senescence
Ng, M., & Hazrati, L.-N. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.08.014 · Cited by 78
“…initiates DDR signaling directly (Chatterjee and Walker, 2017), oncogene activation leads to DNA hyperreplication and subsequent replication stress (Di Micco et al., 2021, 2006), and oxidative stress produces replication stress as well as single-strand breaks (SSBs) (Venkatachalam et al., 2017).”
Tumor suppression by p53: making cells senescent.
Qian, Y., & Chen, X. (2010) · PubMed · doi:10.14670/hh-25.515 · Cited by 85
“Third, OIS is an outcome of a DNA damage response (Di Micco et al., 2006).”
p38α and p38γ Mediate Oncogenic ras-induced Senescence through Differential Mechanisms
Kwong, J., Hong, L., Liao, R., Deng, Q., Han, J., & Sun, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808327200 · Cited by 82
Mannava, S., Moparthy, K. C., Wheeler, L. J., Natarajan, V., Zucker, S. N., Fink, E. E., Im, M., Flanagan, S., Burhans, W. C., Zeitouni, N. C., et al. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.09.011 · Cited by 82
“DNA hyper-replication (multiple firing of the same replication origin) was proposed to be a primary cause for this phenotype (6).”
BackgroundInfluentialYu, H., McDaid, R., Lee, J., Possik, P. A., Li, L., Kumar, S. M., Elder, D. E., Belle, P. A. V., Gimotty, P. A., Guerra, M., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081057 · Cited by 94
Crosstalk between the Rb pathway and AKT signaling forms a quiescence-senescence switch.
Imai, Y., Takahashi, A., Hanyu, A., Hori, S., Sato, S., Naka, K., Hirao, A., Ohtani, N., & Hara, E. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.006 · Cited by 84
Suppression of p16 alleviates the senescence-associated secretory phenotype
(2021) · doi:10.18632/aging.202640 · Cited by 84
The complex basis underlying common fragile site instability in cancer
Ozeri-Galai, E., Bester, A. C., & Kerem, B. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.02.006 · Cited by 97
Miles, S., Li, L., Davison, J., & Breeden, L. L. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003854 · Cited by 91
“Related effects have been observed with excess cyclin E, and other activated oncogenes in higher cells [50,51] and in yeast [26,27,52].”
BackgroundMiz1 and HectH9 regulate the stability of the checkpoint protein, TopBP1
Herold, S., Hock, A., Herkert, B., Berns, K., Mullenders, J., Beijersbergen, R. L., Bernards, R., & Eilers, M. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.200 · Cited by 93
“Senescence is considered a tumour-protective mechanism that limits oncogenic transformation by Ras; furthermore, Ras-induced senescence is closely related to and involves components of the DNA damage response pathway (Di Micco et al, 2006).”
BackgroundCamps, J., Grade, M., Nguyen, Q. T., Hörmann, P., Becker, S., Hummon, A. B., Rodriguez, V., Chandrasekharappa, S. C., Chen, Y., Difilippantonio, M. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2864 · Cited by 84
“Oncogeneinduced senescence has recently been shown to induce a DNA damage response in tissue culture models ( 41 , 42) as well as in vivo during the development of thymocytes (43), and is able to restrict the growth of human and murine precancerous tissues (44–48).”
BackgroundMenendez, J. A., Cufí, S., Oliveras-Ferraros, C., Martin-Castillo, B., Joven, J., Vellon, L., & Vazquez-Martin, A. (2011) · Aging · doi:10.18632/aging.100407 · Cited by 85
“This appears to be similar to what occurs during oncogene-induced senescence (OIS), when cell proliferation and transformation induced by oncogene activation in early tumorigenesis is restrained by cellular senescence, which results from the ATMmediated DDR triggered by oncogene-induced DNA hyper-replication [69, 70].”
BackgroundPathways for maintenance of telomeres and common fragile sites during DNA replication stress
Özer, Ö., & Hickson, I. D. (2018) · Open Biology · doi:10.1098/rsob.180018 · Cited by 89
“org Open Biol:180018 2 chronic DNA replication stress [5,7,8].”
BackgroundCellular senescence: a hitchhiker’s guide
Aravinthan, A. (2015) · Human Cell · doi:10.1007/s13577-015-0110-x · Cited by 72
“This is corroborated by a study which demonstrated a strong association between oncogene-induced senescence and the DDR, while inactivation of the DDR abrogated such senescence [92].”
Is cellular senescence an example of antagonistic pleiotropy?
Giaimo, S., & d’Adda di Fagagna, F. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00807.x · Cited by 77
“However, when they become activated in absence of other tumour-suppressor inactivating mutations, cells arrest proliferation and undergo cellular senescence associated with chronic DDR (Serrano et al., 1997; Bartkova et al., 2006; Di Micco et al., 2006; Halazonetis et al., 2008).”
BackgroundTherapeutic targeting of replicative immortality
Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., Firestone, G. L., Matheu, A., Carnero, A., Bilsland, A. E., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.007 · Cited by 97
“[72] Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, et al.”
BackgroundYang, M.-Y., Lin, P.-M., Liu, Y.-C., Hsiao, H.-H., Yang, W.-C., Hsu, J.-F., Hsu, C.-M., & Lin, S.-F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037205 · Cited by 83
“In addition, some other senescence-associated genes such as CDC6, its overexpression was reported to be sufficient to induce DNA damage and senescence [33].”
BackgroundThe Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo
Reimann, M., Loddenkemper, C., Rudolph, C., Schildhauer, I., Teichmann, B., Stein, H., Schlegelberger, B., Dörken, B., & Schmitt, C. A. (2007) · Blood · doi:10.1182/blood-2007-02-075614 · Cited by 78
“Indeed, prototypic oncogenes such as Myc and Ras have been reported to cause DNA damage, possibly via the production of reactive oxygen species (ROS),(11,12) or by generating aberrant DNA replication intermediates.(13,14) Conversely, inherited DDR defects as known from ataxia telangiectasia (A-T),(15) the Nijmegen bre…”
BackgroundStudies of genomic copy number changes in human cancers reveal signatures of DNA replication stress
Dereli‐Öz, A., Versini, G., & Halazonetis, T. D. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.05.002 · Cited by 91
“In addition, evidence has been obtained in various experimental systems that activated oncogenes induce collapse of DNA replication forks and replication-dependent induction of DNA DSBs (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundCellular Senescence and Vascular Disease: Novel Routes to Better Understanding and Therapy
Yin, H., & Pickering, J. G. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.051 · Cited by 82
Romanov, V. S., Abramova, M. V., Svetlikova, S. B., Bykova, T. V., Zubova, S. G., Aksenov, N. D., Fornace, A. J., Pospelova, T. V., & Pospelov, V. A. (2010) · Cell Cycle · doi:10.4161/cc.9.19.13160 · Cited by 80
“Transformation of normal cells induced by oncogene activation is restrained by triggering the program of cellular senescence.(6,7) The block of cell cycle in case of premature cell senescence has many common features with cell cycle arrest, which is induced by DNA damaging and stress factors and is often based on acti…”
BackgroundUpregulation of FOXM1 induces genomic instability in human epidermal keratinocytes
Teh, M., Gemenetzidis, E., Chaplin, T., Young, B. D., & Philpott, M. P. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-45 · Cited by 97
Chitikova, Z. V., Gordeev, S. A., Bykova, T. V., Zubova, S. G., Pospelov, V. A., & Pospelova, T. V. (2014) · Cell Cycle · doi:10.4161/cc.28402 · Cited by 77
“A large number of works demonstrate that establishment and maintenance of various types of cellular senescence are associated with the activation of DDR signaling and persistence of DDR foci.(1,11,15,28,54,55) The foci persistent in senescent cells may also reflect the chromatin rearrangement in the absence of DNA bre…”
BackgroundATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D
Komura, K., Yoshikawa, Y., Shimamura, T., Chakraborty, G., Gerke, T. A., Hinohara, K., Chadalavada, K., Jeong, S. H., Armenia, J., Du, S.-Y., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96769 · Cited by 84
Cell senescence in neuropathology: A focus on neurodegeneration and tumours
Carreno, G., Guiho, R., & Martinez‐Barbera, J. P. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12689 · Cited by 74
Lazorthes, S., Vallot, C., Briois, S., Aguirrebengoa, M., Thuret, J.-Y., Laurent, G. S., Rougeulle, C., Kapranov, P., Mann, C., Trouche, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms6971 · Cited by 78
Lessons from senescence: Chromatin maintenance in non-proliferating cells
Rai, T. S., & Adams, P. D. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.07.014 · Cited by 71
Corpet, A., Olbrich, T., Gwerder, M., Fink, D., & Stucki, M. (2014) · Cell Cycle · doi:10.4161/cc.26988 · Cited by 71
Complex engagement of DNA damage response pathways in human cancer and in lung tumor progression
Nuciforo, P. G., Luise, C., Capra, M., Pelosi, G., & d'Adda di Fagagna, F. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm108 · Cited by 80
Self-citationBreaking news: high-speed race ends in arrest – how oncogenes induce senescence
Micco, R. D., Fumagalli, M., & di Fagagna, F. D. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.07.012 · Cited by 94
Self-citationNakamura, M., Ohsawa, S., & Igaki, T. (2014) · Nature Communications · doi:10.1038/ncomms6264 · Cited by 79
The DNA-damage response and nuclear events as regulators of nonapoptotic forms of cell death
Prokhorova, E. A., Egorshina, A. Y., Zhivotovsky, B., & Kopeina, G. S. (2019) · Oncogene · doi:10.1038/s41388-019-0980-6 · Cited by 83
Unexpected Pieces to the Senescence Puzzle
Cichowski, K. M., & Hahn, W. C. (2008) · Cell · doi:10.1016/j.cell.2008.05.027 · Cited by 86
“Similarly, the DNAdamage response pathway serine/threonine kinase ATM and the p53 regulator ARF may collaborate in response to certain oncogenic insults to potentiate p53 activation (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007).”
BackgroundHow cells switch HIPK2 on and off
Sombroek, D., & Hofmann, T. G. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.154 · Cited by 87
MicroRNA controls of cellular senescence
Suh, N. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.10.209 · Cited by 78
“miRNAs associated with the p16-pRB pathway miRNAs directly regulate p16: The other core converged pathways during cellular senescence is p16-pRB (66, 67).”
Backgroundc-Myc Accelerates S-Phase and Requires WRN to Avoid Replication Stress
Robinson, K., Asawachaicharn, N., Galloway, D. A., & Grandori, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005951 · Cited by 75
“Recent literature indicates that a hyper-replication phenotype leading to a DNA damage response and senescence is a common consequence to expression of activated ras and mos [36,37].”
BackgroundThresholds of replication stress signaling in cancer development and treatment
Bártek, J., Mistrík, M., & Bártková, J. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2220 · Cited by 88
The acetyltransferase Tip60 contributes to mammary tumorigenesis by modulating DNA repair
Bassi, C., Li, Y.-T., Khu, K., Mateo, F., Baniasadi, P. S., Elia, A., Mason, J., Stambolic, V, Pujana, M. A., Mak, T. W., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.173 · Cited by 76
Xu, M., Yu, Q., Subrahmanyam, R., Difilippantonio, M. J., Ried, T., & Sen, J. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01360-07 · Cited by 75
“Furthermore, in vivo DNA labeling and molecular DNA combing studies showed that oncogene activation led to an increased number of active replicons and altered DNA replication fork progression (10).”
BackgroundThe relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence
Haferkamp, S., Tran, S. L., Becker, T. M., Scurr, L. L., Kefford, R. F., & Rizos, H. (2009) · Aging · doi:10.18632/aging.100051 · Cited by 77
Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers
Knauf, J. A., Luckett, K. A., Chen, K.-Y., Voza, F. A., Socci, N. D., Ghossein, R. A., & Fagin, J. A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120966 · Cited by 81
Aging of Liver in Its Different Diseases
Radonjić, T., Dukić, M., Jovanović, I., Zdravkovic, M. D., Mandić, O., Popadić, V., Popović, M., Nikolić, N., Klašnja, S., Divac, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113085 · Cited by 84
Cyclin E Deregulation Promotes Loss of Specific Genomic Regions
Teixeira, L. K., Wang, X., Li, Y., Ekholm‐Reed, S., Wu, X., Wang, P., & Reed, S. I. (2015) · Current Biology · doi:10.1016/j.cub.2015.03.022 · Cited by 83
Ras-Induced Senescence and its Physiological Relevance in Cancer
DiMauro, T., & David, G. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910793357998 · Cited by 76
“Importantly, these studies also report that activation of the DNA damage response is required for oncogene-induced senescence, as supported by the lack of senescence upon genetic or chemical inactivation of CHK2, ATM or p53 [33,60].”
BackgroundHuman Nuclease/Helicase DNA2 Alleviates Replication Stress by Promoting DNA End Resection
Peng, G., Dai, H., Zhang, W., Hsieh, H.-J., Pan, M.-R., Park, Y.-Y., Tsai, R. Y.-L., Bedrosian, I., Lee, J.-S., Ira, G., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3152 · Cited by 73
“Recent studies have indicated that oncogene-induced replication stress underlies DSB formation (4, 5).”
InfluentialAkt/PKB suppresses DNA damage processing and checkpoint activation in late G2
Xu, N., Hégarat, N., Black, E. J., Scott, M. T., Hochegger, H., & Gillespie, D. A. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201003004 · Cited by 87
“The early stages of neoplasia are often associated with spontaneous genotoxic stress, and the resulting DNA damage signaling can elicit tumor-suppressive responses such as cell senescence or apoptosis (Bartkova et al., 2006; Di Micco et al., 2006; Toledo et al., 2008).”
Willis, C. M., Nicaise, A. M., Bongarzone, E. R., Givogri, M., Reiter, C. R., Heintz, O., Jellison, E. R., Sutter, P. A., TeHennepe, G., Ananda, G., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-57663-x · Cited by 76
STAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferation
Koganti, S. R. K., Hui‐Yuen, J. S., McAllister, S. C., Gardner, B., Grässer, F. A., Palendira, U., Tangye, S. G., Freeman, A. F., & Bhaduri‐McIntosh, S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400683111 · Cited by 83
“Because apoptosis and intra-S phase arrest of EBV-infected STAT3-deficient B cells (19) is consistent with EBV oncogene-driven replication stress (3, 21), we examined the effect of EBV infection on replication protein A (RPA) and ataxia telangiectasia and Rad3 related (ATR) proteins.”
BackgroundThe controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy
Cao, L., Li, K., Li, Q., Tong, Q., Wang, Y., & Huang, L. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02475-8 · Cited by 93
In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells
Leikam, C., Hufnagel, A. L., Otto, C., Murphy, D. J., Mühling, B., Kneitz, S., Nanda, I., Schmid, M., Wagner, T. U., Haferkamp, S., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.71 · Cited by 74
DNA double-strand breaks: A potential causative factor for mammalian aging?
Li, H., Mitchell, J. R., & Hasty, P. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.02.002 · Cited by 83
Epithelial cell senescence: an adaptive response to pre-carcinogenic stresses?
Abbadie, C., Pluquet, O., & Pourtier, A. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2587-9 · Cited by 83
Lindqvist, A., de Bruijn, M., Macurek, L., Brás, A., Mensinga, A., Bruinsma, W., Voets, O., Kranenburg, O., & Medema, R. H. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.246 · Cited by 75
“Interestingly, both early during tumour development and after genotoxic anti-cancer treatment a DNA damage checkpoint is activated, which cells must overcome to continue to proliferate (Bartkova et al, 2006; Di Micco et al, 2006).”
BackgroundKey concepts in glioblastoma therapy
Bartek, J., Ng, K., Bartek, J., Fischer, W., Carter, B., & Chen, C. C. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300709 · Cited by 72
Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy
Ferrari, S., Valeri, E., Conti, A., Scala, S., Aprile, A., Di Micco, R., Kajaste-Rudnitski, A., Montini, E., Ferrari, G., Aiuti, A., et al. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.04.014 · Cited by 70
Lyons, C. E., Razzoli, M., & Bartolomucci, A. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105359 · Cited by 81
Wilhelm, T., Ragu, S., Magdalou, I., Machon, C., Dardillac, E., Técher, H., Guitton, J., Debatisse, M., & López, B. S. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006007 · Cited by 79
Meyer, P., Maity, P., Burkovski, A., Schwab, J., Müssel, C., Singh, K., Ferreira, F. F., Krug, L., Maier, H. J., Wlaschek, M., et al. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005741 · Cited by 75
Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype
Lau, L., & David, G. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1565658 · Cited by 70
Origanti, S., Cai, S.-R., Munir, A. Z., White, L. S., & Piwnica-Worms, H. (2013) · Oncogene · doi:10.1038/onc.2012.84 · Cited by 74
“Oncogenic stress activates the ATR/Chk1 pathway (34–36) and tumor cells depend on this signaling pathway to maintain some semblance of genome stability (37).”
Mansour, W. Y., Bogdanova, N. V., Kasten-Pisula, U., Rieckmann, T., Köcher, S., Borgmann, K., Baumann, M. A., Krause, M., Petersen, C., Hu, H., et al. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.10.020 · Cited by 78
“ATM-mediated DNA damage response (DDR) is a physiological barrier which is attenuated during carcinogenesis [29–33].”
BackgroundVelichko, A. K., Petrova, N. V., Razin, S. V., & Kantidze, O. L. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv573 · Cited by 73
“DDR activation is essential for the establishment of certain cellular senescence states, particularly the oncogeneinduced senescence (19).”
BackgroundParallel pathways in RAF-induced senescence and conditions for its reversion
Jeanblanc, M., Ragu, S., Gey, C., Contrepois, K., Courbeyrette, R., Thuret, J., & Mann, C. (2011) · Oncogene · doi:10.1038/onc.2011.481 · Cited by 80
Lin, H.-Y., Kao, C., Lin, K. M.-C., Kaartinen, V., & Yang, L.-T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015842 · Cited by 82
“Aberrant activation of bulge stem cells may create a replication stress that triggers DDR, and this notion is supported by several findings which correlate oncogene-induced aberrant DNA replication with DSB generation [48,49,50,51].”
BackgroundThe emerging role of p53 in stem cells
Bonizzi, G., Cicalese, A., Insinga, A., & Pelicci, P. G. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.08.002 · Cited by 78
Self-citation
Metadata
- Authors
- Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., Maestro, R., Giuseppe Pelicci, P., & d’Adda di Fagagna, F.
- Affiliations
- IFOM (IT)
- European Institute of Oncology (IT)
- Centro di Riferimento Oncologico (IT)
- Institut Pasteur (FR)
- Genomic Vision (France) (FR)
- Venue
- Nature
- Published
- 2006-11
- Volume
- 444
- Issue
- 7119
- Pages
- 638-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2121371748
- Cited by
- 1,821
- References
- 30
- Citations by year
- 2026: 50 · 2025: 58 · 2024: 62 · 2023: 76 · 2022: 80 · 2021: 118 · 2020: 84 · 2019: 81 · 2018: 104 · 2017: 84 · 2016: 110 · 2015: 89 · 2014: 118 · 2013: 107 · 2012: 115
- FWCI
- 58.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- oncogene-induced senescence, DNA damage response, H-Ras V12, origin of replication, DNA replication fork progression, cell transformation, carcinogenesis, senescence markers, DNA combing
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Cells, Cultured, DNA Replication, Genetic Markers, Humans, Genes, ras, Cellular Senescence, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.